DRUG FACTS:

Manufacturer
Nutritional Specialties, Inc.
Effective date
2026-05-18
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 02:38:37

Label at a glance#

ProductViri Sode
Active ingredientHUMAN HERPESVIRUS 5, HUMAN HERPESVIRUS 1, HUMAN HERPESVIRUS 2, INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE, INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE, RUBELLA VIRUS, HEPATITIS A VIRUS, HEPATITIS B VIRUS, HEPATITIS C VIRUS, HUMAN HERPESVIRUS 4, HUMAN HERPESVIRUS 3
Label structure9 sections

Indications and uses

Aids in temporary relief of symptoms including •fatigue, •occasional headaches, •sweats, •chills, •runny nose, and •minor aches of muscles and joints. †Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Dosage and administration

• Adults: 2 to 3 sprays orally, three times daily. • Children under twelve one half adult dosage. For highly sensitive individuals: best tolerated administration is through imbrication (RUBBING IN)    on skin at pulse points or abdomen. • Do not take within 15 minutes of consuming food, beverage or brushing teeth. • Consult a physician for use in children under 12 years of age.

Label contents#

Full prescribing information#

ACTIVE INGREDIENTS:

OTC - ACTIVE INGREDIENT SECTION

(in each spray) Cytomegalovirus Nosode 16X, Epstein-Barr Virus Nosode 15C, Hepatitis A Nosode 30X, Hepatitis B Nosode 30X, Hepatitis C Nosode 30X, Herpes Simplex I & II Nosode 30X, Herpes Zoster Nosode 15C, Influenzinum 15C, Rubella Nosode 16X.

PURPOSE:

OTC - PURPOSE SECTION

Cytomegalovirus Nosode – Aids in Temporary Relief of Fatigue, Headaches, Sweats, Chills, and Aches of Muscles and Joints,† Epstein-Barr Virus Nosode - Aids in Temporary Relief of Fatigue, Headaches, Sweats, Chills, and Aches of Muscles and Joints,† Hepatitis A Nosode - Aids in Temporary Relief of Fatigue, Sweats, Chills, and Aches of Joints,† Hepatitis B Nosode - Aids in Temporary Relief of Fatigue, and Aches of Muscles and Joints,† Hepatitis C Nosode - Aids in Temporary Relief of Fatigue, Sweats, Chills, and Aches of Muscles and Joints,† Herpes Simplex I & II Nosode – Aids in Temporary Relief of Headaches,† Herpes Zoster Nosode - Aids in Temporary Relief of Fatigue, Headaches, Sweats and Chills,† Influenzinum - Aids in Temporary Relief of Fatigue, Headaches, Sweats, Chills, Runny Nose and Aches of Muscles and Joints,† Rubella Nosode - Aids in Temporary Relief of Headaches, Sweats, Chills, Runny Nose and Aches of Muscles and Joints†

†Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

USES:

INDICATIONS & USAGE SECTION

Aids in temporary relief of symptoms including •fatigue, •occasional headaches, •sweats, •chills, •runny nose, and •minor aches of muscles and joints.

†Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

WARNINGS:

WARNINGS SECTION

If pregnant or breast-feeding, ask a health professional before use.

In case of overdose, get medical help or contact a Poison Control Center right away.

If condition worsens, seek medical attention.

KEEP OUT OF REACH OF CHILDREN

Do not use if tamper evident seal is broken or missing.

Store in a cool place after opening

KEEP OUT OF REACH OF CHILDREN:

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away.

DIRECTIONS:

DOSAGE & ADMINISTRATION SECTION

• Adults: 2 to 3 sprays orally, three times daily.

• Children under twelve one half adult dosage. For highly sensitive individuals: best tolerated administration is through imbrication (RUBBING IN)    on skin at pulse points or abdomen.

• Do not take within 15 minutes of consuming food, beverage or brushing teeth.

• Consult a physician for use in children under 12 years of age.

INACTIVE INGREDIENTS:

INACTIVE INGREDIENT SECTION

Alcohol USP 20%, Purified Water USP.

QUESTIONS:

OTC - QUESTIONS SECTION

MANUFACTURED EXCLUSIVELY FOR

NUTRITIONAL SPECIALTIES, INC.

PO BOX 97227

PITTSBURGH, PA 15229

www.phpitd.com

1-800-245-1313

PACKAGE LABEL DISPLAY:

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Professional Health Products

HOMEOPATHIC

NDC 83027-0304-1

VIRI-SODE

2 FL. OZ. (60 ml)

VIRI-SODEVIRI-SODE

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130649818014030GTIN-13: 0649818014030
EAN-13: 0649818014030
GTIN-12: 649818014030
UPC-A: 649818014030
GTIN storage (14 digits): 00649818014030
NSPC0079 Viri Sode 3-6-26.jpg

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
83027-0304-1Viri Sode60 mL in 1 BOTTLE, SPRAYSPRAY601

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 17 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
83027-030483027-0304-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 15 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Viri SodeCYTOMEGALOVIRUS NOSODE, HERPES SIMPLEX I AND II NOSODE, INFLUENZINUM, RUBELLA NOSODE, HEPATITIS A NOSODE, HEPATITIS B NOSODE, HEPATITIS C NOSODE, EPSTEIN-BARR VIRUS NOSODE, HERPES ZOSTER NOSODENutritional Specialties, Inc.8fb280d9-b79f-4b44-a534-89ddda0c27782026-05-18WarningsExact identifier
ndc (package): 83027-0304-1
ndc (product): 83027-0304
ndc11 (package): 83027030401
spl id: 227036bb-4d7c-4963-a1bf-008cafedfdf9
spl set id: 8fb280d9-b79f-4b44-a534-89ddda0c2778

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.